BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23047552)

  • 1. Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.
    Wong CK; Namdarian B; Chua J; Chin X; Speirs R; Nguyen T; Fankhauser M; Pedersen J; Costello AJ; Corcoran NM; Hovens CM
    Br J Cancer; 2012 Oct; 107(9):1564-73. PubMed ID: 23047552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.
    Starlinger P; Brugger P; Reiter C; Schauer D; Sommerfeldt S; Tamandl D; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C
    Neoplasia; 2011 Oct; 13(10):980-90. PubMed ID: 22028623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.
    de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA
    Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies.
    Yu HK; Lee HJ; Choi HN; Ahn JH; Choi JY; Song HS; Lee KH; Yoon Y; Yi LS; Kim JS; Kim SJ; Kim TJ
    Clin Cancer Res; 2013 Oct; 19(19):5340-50. PubMed ID: 23922300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
    DuBois SG; Stempak D; Wu B; Mokhtari RB; Nayar R; Janeway KA; Goldsby R; Grier HE; Baruchel S
    Pediatr Blood Cancer; 2012 Feb; 58(2):181-4. PubMed ID: 21319292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
    Vergis R; Corbishley CM; Norman AR; Bartlett J; Jhavar S; Borre M; Heeboll S; Horwich A; Huddart R; Khoo V; Eeles R; Cooper C; Sydes M; Dearnaley D; Parker C
    Lancet Oncol; 2008 Apr; 9(4):342-51. PubMed ID: 18343725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
    World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma.
    Namdarian B; Tan KV; Fankhauser MJ; Nguyen TT; Corcoran NM; Costello AJ; Hovens CM
    BJU Int; 2010 Oct; 106(7):1081-7. PubMed ID: 20201835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
    Goon PK; Lip GY; Stonelake PS; Blann AD
    Neoplasia; 2009 Aug; 11(8):771-9. PubMed ID: 19649207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells.
    Delorme B; Basire A; Gentile C; Sabatier F; Monsonis F; Desouches C; Blot-Chabaud M; Uzan G; Sampol J; Dignat-George F
    Thromb Haemost; 2005 Dec; 94(6):1270-9. PubMed ID: 16411405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.
    Mancuso P; Calleri A; Gregato G; Labanca V; Quarna J; Antoniotti P; Cuppini L; Finocchiaro G; Eoli M; Rosti V; Bertolini F
    PLoS One; 2014; 9(12):e114713. PubMed ID: 25506915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
    Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK
    J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
    Rubin MA; Buyyounouski M; Bagiella E; Sharir S; Neugut A; Benson M; de la Taille A; Katz AE; Olsson CA; Ennis RD
    Urology; 1999 Mar; 53(3):542-7. PubMed ID: 10096381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
    Revelos K; Petraki C; Scorilas A; Stefanakis S; Malovrouvas D; Alevizopoulos N; Kanellis G; Halapas A; Koutsilieris M
    Anticancer Res; 2007; 27(5B):3651-60. PubMed ID: 17972531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial cells as biomarkers in clinical oncology.
    Mancuso P; Bertolini F
    Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers.
    Reeves F; Sapre N; Corcoran N; Hovens C
    Biomark Med; 2013 Dec; 7(6):879-91. PubMed ID: 24266820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.
    Beerepoot LV; Mehra N; Vermaat JS; Zonnenberg BA; Gebbink MF; Voest EE
    Ann Oncol; 2004 Jan; 15(1):139-45. PubMed ID: 14679134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating endothelial cells as a novel marker of angiogenesis.
    Mancuso P; Calleri A; Cassi C; Gobbi A; Capillo M; Pruneri G; Martinelli G; Bertolini F
    Adv Exp Med Biol; 2003; 522():83-97. PubMed ID: 12674213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.